In our study, higher RUNX2 expression was detected in GII tumors compared to GI tumors, whereas NKX2-1 seemed to be specifically expressed in GI tumors (Additional file 1: Figure S7C and D). Here, NKX2-1 is linked to digestive system neoplasm.